Tag: drug prices in DTC ads

drug prices in DTC ads

DTC Advertising

Amendment to Fund Drug Prices in Ads Dropped to Avert Derailment of HHS Spending Bill

Amendment to Fund Drug Prices in Ads Dropped to Avert Derailment of HHS Spending Bill

Sept. 24, 2018 — With the amendment to fund the implementation of mandatory drug prices in consumer advertising stripped out of the spending bill to which it had been attached, the question of whether or how quickly this drug pricing mandate will move forward remains unclear. The amendment, from Sens. Dick Durbin (D-Ill.) and Charles […]

Read more

DTC Advertising

Mandated Drug Pricing Disclosures in DTC Ads Loom Large

Mandated Drug Pricing Disclosures in DTC Ads Loom Large

Sept. 10, 2018 – Movement toward mandating that drug companies include product prices in consumer-directed ads continues this fall as Congress and the Trump administration push for greater transparency in drug pricing. On Aug. 23, the Senate voted to include an amendment sponsored by Sens. Dick Durbin (D-Ill.) and Chuck Grassley (R-Iowa) to a spending […]

Read more

DTC Advertising

Senate and HHS Make Moves to Advance Mandatory Drug Prices in Consumer Ads

Senate and HHS Make Moves to Advance Mandatory Drug Prices in Consumer Ads

Aug. 24, 2018 – Yesterday was a one-two punch in the Trump administration’s effort to move forward a plan to require that drug manufacturers include drug prices in ads directed toward consumers, as the White House Office of Management and Budget (OMB) reviews a proposed rule from the Department of Health & Human Services (HHS) […]

Read more

Legislative

House Appropriations Bill Does Not Include Authorization of Mandatory Drug Prices in Ads

House Appropriations Bill Does Not Include Authorization of Mandatory Drug Prices in Ads

July 13, 2018 – On the “no news is good news” front, the House Appropriations Committee voted this week on next year’s funding level for the U.S. Department of Health and Human Services (HHS) without taking up an amendment to give HHS and FDA explicit authority to mandate drug list prices in consumer advertising. “What […]

Read more

CHC News

Rawson Shares Short- and Long-term Drug Pricing Fallout at CHC Meeting

Rawson Shares Short- and Long-term Drug Pricing Fallout at CHC Meeting

May 29, 2018 – As the dust settles on the Trump administration’s drug pricing blueprint, the pharmaceutical industry is facing a mixed bag of potential short- and long-term impacts, according to Kate Rawson, Senior Editor, Prevision Policy and The RPM Report. Rawson, who spoke May 23 at the Coalition for Healthcare Communication Rising Leaders Conference […]

Read more

DTC Advertising

Debate over Listing Drug Prices in Ads Continues

Debate over Listing Drug Prices in Ads Continues

May 21, 2018 – Since the Trump administration presented its proposal to lower drug pricing on May 11, both the trade and mainstream media have been discussing whether one provision – a request that the Department of Health & Human Services evaluate the inclusion of drug prices in consumer ads – really has legs. In […]

Read more